Abomics Oy is a company that specializes in translating genomics research into clinical practice and provides new approaches to personalized medicine.
Now Abomics has sealed a deal with International Clinical Research Center (ICRC) in Brno, Czech Republic. ICRC is a new generation science and research center with modern approach on technologies and methods for effective individualized treatment of cardiovascular and neurological diseases. Abomics and ICRC have agreed that Abomics will be co-operating with the research center as a pilot in order to provide pharmacogenetics profiles for 250 of heart condition sample cases. The future prospects for joint collaboration also look very likely as the results have been established. From the interpretations
received from Abomics, ICRC will draw conclusions of medical safety and efficancy of each sampled unit.
Read the full press release here.